Tomoyasu Tsushima

2.2k total citations
101 papers, 1.6k citations indexed

About

Tomoyasu Tsushima is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Tomoyasu Tsushima has authored 101 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 53 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Tomoyasu Tsushima's work include Bladder and Urothelial Cancer Treatments (43 papers), Renal cell carcinoma treatment (22 papers) and Urinary and Genital Oncology Studies (22 papers). Tomoyasu Tsushima is often cited by papers focused on Bladder and Urothelial Cancer Treatments (43 papers), Renal cell carcinoma treatment (22 papers) and Urinary and Genital Oncology Studies (22 papers). Tomoyasu Tsushima collaborates with scholars based in Japan, United States and United Kingdom. Tomoyasu Tsushima's co-authors include Hiromi Kumon, Yasutomo Nasu, Takashi Saika, Shin Ebara, Hideyuki Akaza, Hiroyuki Ohmori, Seiji Naito, Yoshihiko Hirao, Haruki Kaku and Seiichiro Ozono and has published in prestigious journals such as Cancer, The Journal of Urology and Urology.

In The Last Decade

Tomoyasu Tsushima

94 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoyasu Tsushima Japan 25 700 673 489 304 218 101 1.6k
Hugues Bittard France 21 366 0.5× 700 1.0× 666 1.4× 253 0.8× 148 0.7× 101 1.6k
Jun Miki Japan 19 630 0.9× 508 0.8× 457 0.9× 559 1.8× 159 0.7× 171 1.6k
Sam D. Graham United States 20 715 1.0× 342 0.5× 280 0.6× 297 1.0× 187 0.9× 49 1.3k
A. Karim Kader United States 24 725 1.0× 770 1.1× 355 0.7× 388 1.3× 294 1.3× 82 1.8k
Tsunenori Kondo Japan 20 850 1.2× 699 1.0× 411 0.8× 349 1.1× 114 0.5× 134 1.5k
Delphine Amsellem‐Ouazana France 19 568 0.8× 394 0.6× 553 1.1× 158 0.5× 92 0.4× 42 1.4k
Robert P. Huben United States 24 894 1.3× 870 1.3× 351 0.7× 397 1.3× 166 0.8× 79 2.0k
Noriomi Miyao Japan 20 450 0.6× 768 1.1× 536 1.1× 299 1.0× 200 0.9× 42 1.4k
M. Kuczyk Germany 12 793 1.1× 798 1.2× 659 1.3× 241 0.8× 221 1.0× 31 1.6k
Mark H. Kawachi United States 18 552 0.8× 403 0.6× 232 0.5× 145 0.5× 178 0.8× 37 1.1k

Countries citing papers authored by Tomoyasu Tsushima

Since Specialization
Citations

This map shows the geographic impact of Tomoyasu Tsushima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyasu Tsushima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyasu Tsushima more than expected).

Fields of papers citing papers by Tomoyasu Tsushima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyasu Tsushima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyasu Tsushima. The network helps show where Tomoyasu Tsushima may publish in the future.

Co-authorship network of co-authors of Tomoyasu Tsushima

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyasu Tsushima. A scholar is included among the top collaborators of Tomoyasu Tsushima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyasu Tsushima. Tomoyasu Tsushima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tsushima, Tomoyasu, et al.. (2022). An autopsy case of autoimmune meningoencephalitis caused by pembrolizumab. Urology Case Reports. 45. 102226–102226. 1 indexed citations
3.
Ito, Keiichi, Shuji Mikami, Katsunori Tatsugami, et al.. (2018). Clinical Outcomes in Patients With Metastatic Papillary Renal-Cell Carcinoma: A Multi-Institutional Study in Japan. Clinical Genitourinary Cancer. 16(6). e1201–e1214. 5 indexed citations
4.
Hinotsu, Shiro, Koji Kawai, Seiichiro Ozono, et al.. (2011). Randomized controlled study of natural interferon α as adjuvant treatment for stage II or III renal cell carcinoma. International Journal of Clinical Oncology. 18(1). 68–74. 9 indexed citations
5.
6.
Ito, Keiichi, Hayakazu Nakazawa, Ken Marumo, et al.. (2008). Risk Factors for Ipsilateral Adrenal Involvement in Renal Cell Carcinoma. Urology. 72(2). 354–358. 10 indexed citations
7.
Ozono, Seiichiro, Hayakazu Nakazawa, Satoshi Nagamori, et al.. (2007). Surgical outcomes of partial nephrectomy for renal cell carcinoma: A joint study by the Japanese Society of Renal Cancer. International Journal of Urology. 14(4). 284–288. 9 indexed citations
8.
Saika, Takashi, Tomoyasu Tsushima, Yasutomo Nasu, et al.. (2003). Anterior urethral recurrence of superficial bladder cancer: its clinical significance.. Okayama University Scientific Achievement Repository (Okayama University). 57(6). 293–7. 2 indexed citations
9.
Kaku, Haruki, Tomoyasu Tsushima, Yasutomo Nasu, et al.. (2002). Combination chemotherapy with estramustine phosphate, ifosfamide and cis-platin in hormone-refractory prostate cancer. 64(4). 236–241. 1 indexed citations
10.
Tsushima, Tomoyasu, et al.. (2001). Optimal Starting Time for Flutamide to Prevent Disease Flare in Prostate Cancer Patients Treated with a Gonadotropin-Releasing Hormone Agonist. Urologia Internationalis. 66(3). 135–139. 26 indexed citations
11.
Nasu, Yasutomo, Nobuyuki Kusaka, Takashi Saika, Tomoyasu Tsushima, & Hiromi Kumon. (2000). Suicide Gene Therapy for Urogenital Cancer: Current Outcome and Prospects. PubMed. 4(2). 67–71. 15 indexed citations
12.
Tsushima, Tomoyasu, Takanori Murakami, Shin Ebara, et al.. (1998). Partial cystectomy in the treatment of invasive bladder cancer. 60(5). 397–401.
13.
Nasu, Yasutomo, et al.. (1995). Renal oncocytoma: A case report. 57(12). 1278–1280.
14.
Tsushima, Tomoyasu, et al.. (1994). Clinicostatistical study of renal pelvic and ureteral tumors. 56(1). 38–43. 1 indexed citations
15.
Saika, Takashi, et al.. (1994). OVER‐EXPRESSION OF METALLOTHIONEIN AND DRUG‐RESISTANCE IN BLADDER CANCER. International Journal of Urology. 1(2). 135–139. 18 indexed citations
16.
Tsushima, Tomoyasu, et al.. (1993). Postoperative adjuvant chemotherapy by early intravesical instillations of epirubicin for the treatment of superficial bladder cancer. 55(1). 43–45. 1 indexed citations
17.
Tsushima, Tomoyasu, et al.. (1992). Bladder-sparing approach for invasive bladder cancer - Preoperative intra-arterial infusion chemotherapy and bladder preservation. 54(4). 441–445. 1 indexed citations
18.
Ohi, Yoshitada, Hiroyuki Ohmori, T Shirahama, et al.. (1992). Intravesical instillation of Adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study. Cancer Chemotherapy and Pharmacology. 30(S1). S50–S54. 13 indexed citations
19.
Kumon, Hiromi, et al.. (1991). Flexible Ureteropyeloscopy : Diagnosis and Treatment of Upper Urinary Tumors. 4(1). 103–105. 2 indexed citations
20.
Ohmori, H., et al.. (1991). Phase 2 study of 5'-DFUR for bladder and prostatic cancer. Gan to kagaku ryōhō. 18(13). 2307–2314. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hugues Bittard Breakdown of academic impact, for papers by Jun Miki Breakdown of academic impact, for papers by Sam D. Graham Breakdown of academic impact, for papers by A. Karim Kader Breakdown of academic impact, for papers by Tsunenori Kondo Breakdown of academic impact, for papers by Delphine Amsellem‐Ouazana Breakdown of academic impact, for papers by Robert P. Huben Breakdown of academic impact, for papers by Noriomi Miyao Breakdown of academic impact, for papers by M. Kuczyk Breakdown of academic impact, for papers by Mark H. Kawachi
Rankless by CCL
2026